HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heme Oxygenase-1 and breast cancer resistance protein protect against heme-induced toxicity.

Abstract
Heme is the functional group of diverse hemoproteins and crucial for many cellular processes. However, heme is increasingly recognized as a culprit for a wide variety of pathologies, including sepsis, malaria, and kidney failure. Excess of free heme can be detrimental to tissues by mediating oxidative and inflammatory injury. Protective mechanisms against free heme are therefore pivotal for cellular survival. We postulated that overexpression of Heme Oxygenase-1 (HO-1) and Breast Cancer Resistance Protein (BCRP) would protect against heme-induced cytotoxicity. HO-1 is a heme-degrading enzyme generating carbon monoxide, iron, and biliverdin/bilirubin, while BCRP is a heme efflux transporter. Human embryonic kidney cells were transduced using a baculovirus system as a novel strategy to efficiently overexpress HO-1 and BCRP. Exposing cells to heme resulted in a dose-dependent increase in reactive oxygen species formation, DNA damage and cell death. Heme-induced cell death was significantly attenuated when cells overexpressed HO-1, BCRP, or both. The protective effects of HO-1 overexpression were most pronounced, while co-treatment with the HO-activity inhibitor tin mesoporphyrin reversed these protective effects. Also cells treated with the anti-oxidants N-acetylcysteine or HO-effector molecule bilirubin showed protection against heme insults, which may explain the increased protection by HO-1 compared to BCRP. In conclusion, both HO-1 and BCRP protect against heme-induced toxicity and may thus form novel therapeutic targets for heme-mediated pathologies.
AuthorsFrank A D T G Wagener, Anita C A Dankers, Frank van Summeren, Alwin Scharstuhl, Jeroen J M W van den Heuvel, Jan B Koenderink, Sebastiaan W C Pennings, Frans G M Russel, Rosalinde Masereeuw
JournalCurrent pharmaceutical design (Curr Pharm Des) Vol. 19 Issue 15 Pg. 2698-707 ( 2013) ISSN: 1873-4286 [Electronic] United Arab Emirates
PMID23092328 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • ABCG2 protein, human
  • ATP Binding Cassette Transporter, Subfamily G, Member 2
  • ATP-Binding Cassette Transporters
  • Benzimidazoles
  • Neoplasm Proteins
  • Oxidants
  • Reactive Oxygen Species
  • Heme
  • Heme Oxygenase-1
  • bisbenzimide ethoxide trihydrochloride
Topics
  • ATP Binding Cassette Transporter, Subfamily G, Member 2
  • ATP-Binding Cassette Transporters (physiology)
  • Benzimidazoles (metabolism)
  • Blotting, Western
  • DNA Damage
  • HEK293 Cells
  • Heme (toxicity)
  • Heme Oxygenase-1 (metabolism)
  • Humans
  • Neoplasm Proteins (physiology)
  • Oxidants (toxicity)
  • Reactive Oxygen Species (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: